EPIQ Series Diagnostic Ultrasound System, Affiniti Series Diagnostic Ultrasound System
by Philips Ultrasound LLC 2 variants
510(k) K233788
Active
Valid until
Not listed
FDA recalls
1 ongoingTrust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE 510(k) | NumberK233788 | Date13 Feb 2024 | StatusActive |
| European Union | CE/MDR EUDAMED | Number— | Date— | StatusActive |
Recalls
-
- Ongoing Z-2409-2025
To provide clarification and labelling to define the useful life of ultrasound transducers in the field.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- 510(k) Number
- FDA Product Code
- IYN
- FDA applicant
- Philips Ultrasound, LLC
- Device Class
- Class II
- Regulation
- 21 CFR Part 892.1550
- Advisory Committee
- Radiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The EPIQ Series and Affiniti Series Diagnostic Ultrasound Systems are advanced diagnostic imaging devices classified as ultrasound systems. They generate real-time visual images of internal body structures using high-frequency sound waves, enabling clinicians to assess organs, tissues, and blood flow for diagnostic purposes.
These systems are supplied as reusable medical devices and are intended for use in clinical settings such as hospitals, diagnostic imaging centers, and outpatient facilities. They are not single-use and require proper maintenance, calibration, and storage as per manufacturer guidelines. The devices are authorized under FDA 510K clearance and comply with MDR regulations, ensuring adherence to safety and performance standards for diagnostic ultrasound applications.